Your browser doesn't support javascript.
loading
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2).
Benfield, Thomas; Rämet, Mika; Valentini, Piero; Seppä, Ilkka; Dagan, Ron; Richmond, Peter; Mercer, Swati; Churchill, Clay; Lupinacci, Robert; McFetridge, Richard; Park, Jun; Wittke, Frederick; Banniettis, Natalie; Musey, Luwy; Bickham, Kara; Kaminski, Janusz.
Afiliación
  • Benfield T; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
  • Rämet M; Faculty of Medicine and Health Technology, Tampere University, and FVR - Finnish Vaccine Research, Tampere, Finland.
  • Valentini P; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Seppä I; Finnish Vaccine Research, Tampere, Finland.
  • Dagan R; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences of the Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Richmond P; School of Medicine, University of Western Australia, Perth, Australia.
  • Mercer S; Merck & Co., Inc., Rahway, NJ, USA.
  • Churchill C; Merck & Co., Inc., Rahway, NJ, USA.
  • Lupinacci R; Merck & Co., Inc., Rahway, NJ, USA.
  • McFetridge R; Merck & Co., Inc., Rahway, NJ, USA.
  • Park J; Merck & Co., Inc., Rahway, NJ, USA.
  • Wittke F; MSD, Zürich, Switzerland.
  • Banniettis N; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: natalie.banniettis@merck.com.
  • Musey L; Merck & Co., Inc., Rahway, NJ, USA.
  • Bickham K; Merck & Co., Inc., Rahway, NJ, USA.
  • Kaminski J; MSD (UK) Limited, London, United Kingdom.
Vaccine ; 41(15): 2456-2465, 2023 04 06.
Article en En | MEDLINE | ID: mdl-36841723
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Tétanos / Haemophilus influenzae tipo b Tipo de estudio: Clinical_trials Límite: Humans / Infant Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Tétanos / Haemophilus influenzae tipo b Tipo de estudio: Clinical_trials Límite: Humans / Infant Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Países Bajos